Impact of clinical pharmacist in an Indian Intensive Care Unit

Hisham, Mohamed; Sivakumar, M; Veerasekar, Ganesh

doi:10.4103/0972-5229.175931

Cited by 20 publications

(18 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Drug dosing adjustment done by the clinical pharmacist included 140 (11.9%) renal dose, 62 (5.2%) hepatic dose, 17 (1.4%) pediatric dose, and 104 (8.8%) insulin dosing modi ications. Clinical pharmacist as a part of multidisciplinary team in our study was associated with a substantially lower rate of adverse drug event caused by medication errors, drug interactions, and drug incompatibilities" [13]. Luisetto M et al, write that (2017) "We think that the clinical ph.…”

Section: Methodsmentioning

confidence: 73%

“…team and remained in the ICU for consultation in the morning, and was available on call throughout the day. The rate of preventable ordering ADEs decreased by 66% from 10.4 per 1000 patient-days (95% con idence interval [CI], [7][8][9][10][11][12][13][14] before the intervention to 3.5 (95% CI, 1-5; P<0.001) after the intervention. In the control unit, the rate was essentially unchanged during the same time periods: 10.9 (95% CI, 6-16) and 12.4 (95% CI, [8][9][10][11][12][13][14][15][16][17] per 1000 patient-days.…”

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

Intensive Care Units (ICU): The clinical pharmacist role to improve clinical outcomes and reduce mortality rate- An undeniable function

Luisetto¹

2017

J Clin Intensive Care Med

View full text Add to dashboard Cite

show abstract

Section: Methodsmentioning

confidence: 73%

Section: Methodsmentioning

confidence: 99%

Intensive Care Units (ICU): The clinical pharmacist role to improve clinical outcomes and reduce mortality rate- An undeniable function

Luisetto¹

2017

J Clin Intensive Care Med

View full text Add to dashboard Cite

show abstract

“…13 Não foram realizadas intervenções no referido estudo, pois de acordo com autores, algumas interações medicamentosas podem não ser clinicamente relevantes para todos os pacientes. 14 No presente estudo, foi observado que 2,26% das prescrições apresentavam incompatibilidades, além disso, realizou-se intervenção de reconciliação medicamentosa em 4,52% das prescrições, números estes mais expressivos do que no estudo realizado no Hospital Israelita Albert Einstein, que das 3.542 prescrições analisadas, foram realizadas 1.238 intervenções de natureza diversa, sendo que 4% eram referentes a incompatibilidades e 0,16% foram de reconciliação e inferior a dados de incompatibilidade observados por outros autores, onde revelou 13,7% de incompatibilidades.…”

Section: Resultsunclassified

“…14 No presente estudo, foi observado que 2,26% das prescrições apresentavam incompatibilidades, além disso, realizou-se intervenção de reconciliação medicamentosa em 4,52% das prescrições, números estes mais expressivos do que no estudo realizado no Hospital Israelita Albert Einstein, que das 3.542 prescrições analisadas, foram realizadas 1.238 intervenções de natureza diversa, sendo que 4% eram referentes a incompatibilidades e 0,16% foram de reconciliação e inferior a dados de incompatibilidade observados por outros autores, onde revelou 13,7% de incompatibilidades. 13,15 Outro autor descreveu que 41,3% dos pacientes avaliados relataram fazer uso de medicamentos em casa, e nestes foi realizado reconciliação medicamentosa. 8 Um estudo de coorte, prospectivo e transversal, realizado na República Checa, com 82 pacientes, verificou que 6,82% dos medicamentos prescritos foram considerados incompatíveis.…”

Section: Resultsunclassified

Atuação do farmacêutico residente em uma unidade de pronto atendimento: contribuindo para a promoção da saúde

Moraes¹,

Rosa²,

Frantz³

et al. 2016

Rev Epidemiol Control Infect

View full text Add to dashboard Cite

http: //dx.doi.org/10.17058/reci.v6i4.8191 Please cite this article in press as: Resultados: Houve predominância do sexo masculino (51,4%), com média de 63,41 anos. Foram identificados 2.087 medicamentos prescritos, com média de 7,9 (± 3,4) medicamentos por prescrição. Das 265 prescrições analisadas, foram encontradas interações medicamentosas em 25,6% e 2,3% de incompatibilidades medicamentosas. Realizaram-se intervenções de trocas de horários em 5,66% e 4,52% de reconciliação medicamentosa. Conclusões: O farmacêutico clínico é de fundamental importância no ambiente hospitalar, visto que o estudo revelou-se uma frequência de 25,66% de interações medicamentosas e 2,26% de incompatibilidades.Realizou-se ainda, intervenções farmacêuticas de trocas de horários de administração de medicamentos em 5,66% das prescrições e em 4,52% de reconciliação medicamentosa, ressaltando assim, que o Serviço de Farmácia Clínica tem grande impacto no aumento da segurança ao paciente e prevenção de eventos adversos. Background and Objectives:The practice of Clinical Pharmacy in hospitals is of utmost importance, as the pharmacist cares for the patient, making it possible the pharmacotherapy optimization, promoting the health and well-being, and preventing diseases and improving the quality of health care. Therefore, the aim of this study was to quantify the occurrence of potential drug interactions, incompatibilities and pharmaceutical interventions carried out on prescriptions of patients treated at an Emergency Care Unit (ECU). Methods: This is a descriptive and quantitative study. The activities were developed in a teaching hospital located in the interior of the state of Rio Grande do Sul from April to July 2016, by resident pharmacists. The study sample consisted of 265 prescriptions of 107 patients. Results: There was a predominance of males (51.4%), with a mean age of 63.41 years. 2,087 prescribed drugs were identified, with a mean of 7.9 (± 3.4) drugs per prescription. Of the 265 analyzed prescriptions, drug interactions were found in 25.6%, as well as 2.3% of drug incompatibilities. RESUMO ABSTRACT

show abstract

“…Several studies demonstrated a significant role of a clinical pharmacist (CP) as a full member of a multidisciplinary team in the intensive care unit (ICU) [1][2][3][4][5]. Full membership of a CP in the ICU team includes the presence at the daily rounds in the ICU, cooperation, and availability for consultations throughout the day [6].…”

Section: Introductionmentioning

confidence: 99%

Interventions of a clinical pharmacist in a medical intensive care unit – a retrospective analysis

Cvikl

Sinkovič

2020

Bosn J of Basic Med Sci

View full text Add to dashboard Cite

Several studies demonstrated a significant decrease in prescription errors, adverse drug events, treatment costs and improved patient outcomes, when a clinical pharmacist (CP) was a full member of a multidisciplinary team in the intensive care unit (ICU). Our aim was to evaluate the activities of a CP, included in a 12-bed medical ICU team of a university hospital in the course of several months. We conducted a retrospective analysis of all the CP' s interventions from March 2017 to November 2017, carried out and documented after reviewing and discussing patients' medical data with the treating ICU physicians. We identified four main categories of CP' s interventions: pharmacotherapy adjustments to kidney function (PAKF category), drug-drug interactions (DDIs category), therapeutic monitoring of drugs with narrow therapeutic index (TDM category), and drug administration by the nasogastric tube (NGT category). During the study period, 533 patients were admitted to the medical ICU. The CP reviewed the medical data of 321 patients and suggested 307 interventions in 95 patients. There were 147 interventions of the PAKF category, 57 interventions of the TDM category, 30 interventions of the NGT category, and 22 interventions of the DDIs category. Fifty-one interventions were unspecified. The majority of all interventions (203/307) were related to antimicrobial drugs. ICU physicians completely accepted 80.2% of the CP' s suggestions.We observed that regular participation of the CP in the medical ICU team contributed to more individualized and improved pharmacological treatment of patients. Therefore, ICU teams should be encouraged to include CPs as regular team members.

show abstract

Impact of clinical pharmacist in an Indian Intensive Care Unit

Cited by 20 publications

References 27 publications

Intensive Care Units (ICU): The clinical pharmacist role to improve clinical outcomes and reduce mortality rate- An undeniable function

Intensive Care Units (ICU): The clinical pharmacist role to improve clinical outcomes and reduce mortality rate- An undeniable function

Atuação do farmacêutico residente em uma unidade de pronto atendimento: contribuindo para a promoção da saúde

Interventions of a clinical pharmacist in a medical intensive care unit – a retrospective analysis

Contact Info

Product

Resources

About